Evidence map›Paper›PMID 33959255›Full record

ArticleJournal of surgical case reports2021

SMARCB1-deficient sinonasal carcinoma: a case report and literature review.

Naoki Yanagawa, Masamichi Suzuki, Ryo Sugimoto, Mitsumasa Osakabe, Noriyuki Uesugi, Kiyoto Shiga, Tamotsu Sugai

Open access · goldAbstract readCase Reports
In one paragraph

Article in Journal of surgical case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Naoki YanagawaDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Masamichi SuzukiDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Ryo SugimotoDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Mitsumasa OsakabeDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Noriyuki UesugiDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Kiyoto ShigaHead and Neck Surgert, Iwate Medical University, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Tamotsu SugaiDepartments of Molecular Diagnostic Pathology, Yahaba-cho, Shiwa-gun, Iwate, Japan.
Yawata Medical Center · JPIwate Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SWItch/Sucrose Non-Fermentable (SWI/SNF) -related matrix-associated actin-dependent regulator of chromatin (SMARC) subfamily B member 1 (SMARCB1) deficient sinonasal carcinoma (SdSNC) is a rare variant of sinonasal undifferentiated carcinoma (SNUC). A 72-year-old man was referred to our hospital with complaints of left facial pain and nasal obstruction. Computed tomography (CI) revealed a tumor 5.5 cm in size in the left nasal cavity. Atypical cells with eosinophilic cytoplasm proliferating as solid nests and exhibiting necrosis were observed and diagnosed as poorly differentiated carcinoma. Carbon ion radiotherapy was performed. Follow-up CI revealed multiple masses in both lungs. Partial resection of the right lung was performed. Proliferating atypical cells with clear-to-eosinophilic cytoplasm were observed and resembled those in the paranasal sinus tumor. Immunohistochemical analysis indicated a metastatic lung tumor derived from the SNUC revealed completely negative SMARCB1 expression in the nuclei of the tumor cells. SdSNC is difficult to diagnose. However, molecular targeted therapy may be useful. Thus, it is necessary and important to recognize this rare cancer accurately.

Identifiers

PMID33959255
PMCPMC8088288
OpenAlexW3157510000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.